Comparison of Contemporary Drug-eluting Coronary Stents - Is Any Stent Better than the Others? [0.03%]
当代药物洗脱冠状动脉支架的比较——哪种支架更优？
William Parker,Javaid Iqbal
William Parker
Percutaneous coronary intervention (PCI) with implantation of a metallic drug-eluting stent (DES) is the mainstay of treatment in patients with significant coronary artery disease or acute coronary syndromes. DESs comprise a metallic platfo...
Fauve A Noordergraaf,Marco Alings
Fauve A Noordergraaf
Factor Xa (FXa) inhibitors are widely used for stroke prevention in patients with nonvalvular atrial fibrillation, and for the treatment and prevention of deep venous thrombosis and pulmonary embolism. Compared with warfarin, individual FXa...
Ratio of Serum Aspartate to Alanine Aminotransferase as a Marker of Isolated Coronary Artery Ectasia and its Severity [0.03%]
天门冬氨酸氨基转移酶与丙氨酸氨基转移酶比值可作为冠状动脉局限性扩张及其严重程度的标志物
Danesh Soltani,Samira Jafari,Haleh Ashraf et al.
Danesh Soltani et al.
Background: Several studies have reported an association between elevated liver enzymes and increased risks for developing inflammatory diseases. The aim of our study was to examine how serum liver transaminases, as inexp...
Persistent Myocardial Ischaemia due to Anaemia in a Patient with Coeliac Disease - A Case Report [0.03%]
一例因小肠克罗恩病伴发贫血导致的心肌缺血的病例报告
Aleksandra Gąsecka,Karolina Kruk,Adam Przybyłkowski et al.
Aleksandra Gąsecka et al.
Introduction: Coeliac disease (CD) is a systemic disease of inappropriate immune response to gluten, and is associated with 10% increased risk of cardiovascular disease. Here we present a case of a young patient with pers...
The Coronary Sinus Reducer - Clinical Evidence and New Perspectives On An Emerging Tool in the Treatment of Refractory Angina [0.03%]
冠状窦调节器-在难治性心绞痛治疗中新出现的一种器械的临床证据和新观点
Carlo Zivelonghi,Stefan Verheye
Carlo Zivelonghi
The coronary sinus reducer represents an emerging therapeutic option for patients suffering from chronic refractory angina. Current data indicate that the population suffering from angina symptoms despite maximal medical therapy and maximal...
James C Blankenship,Matthew J Shellenberger
James C Blankenship
Antiplatelet agents are routinely given to prevent thrombosis of coronary stents. Often this occurs during or immediately after the procedure, while the patient is still on the catheterisation laboratory table. Ingestion of pills while supi...
Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial? [0.03%]
ISCHEMIA试验后，在稳定型冠状动脉疾病治疗中血运重建术还有其适应症吗？
Andre Briosa E Gala,Nick Curzen
Andre Briosa E Gala
The ISCHEMIA trial (International study of comparative health effectiveness with medical and invasive approaches; ClinicalTrials.gov Identifier: NCT01471522) has informed practice in patients with stable angina and confirms what other less ...
New Consumer Guidance on Wearable Devices from the Consumer Electronics Show 2020 [0.03%]
2020国际消费电子展发布可穿戴设备消费者新指南
Nassir F Marrouche
Nassir F Marrouche
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia [0.03%]
Etripamil鼻喷雾剂用于家庭治疗急性阵发性室上性心动过速的最新研究进展
Gavin S Chu,Dhiraj Gupta
Gavin S Chu
The current treatment of sustained paroxysmal supraventricular tachycardia (PSVT) often requires attendance at a medical facility. This burden is driven by the lack of an effective self-administered treatment for PSVT. Etripamil (Milestone ...
The Evolving Role of Omega 3 Fatty Acids in Cardiovascular Disease: Is Icosapent Ethyl the Answer? [0.03%]
心血管疾病中的欧米茄-3脂肪酸的作用日益增强：乙基二十碳五烯酸是答案吗？
Suvasini Lakshmanan,Matthew J Budoff
Suvasini Lakshmanan
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality globally. Despite significant advances in pharmacotherapies and the beneficial effects of statin therapy on ASCVD outcomes and progression o...